Supplement: TX HB3286 | 2023-2024 | 88th Legislature | Fiscal Note (Introduced)
For additional supplements on Texas HB3286 please see the Bill Drafting List
Bill Title: Relating to prescription drug benefits under Medicaid and the child health plan program.
Status: 2023-06-12 - Effective on 9/1/23 [HB3286 Detail]
Download: Texas-2023-HB3286-Fiscal_Note_Introduced_.html
Bill Title: Relating to prescription drug benefits under Medicaid and the child health plan program.
Status: 2023-06-12 - Effective on 9/1/23 [HB3286 Detail]
Download: Texas-2023-HB3286-Fiscal_Note_Introduced_.html
| TO: |
Honorable Sam Harless, Chair, House Committee on Health Care Reform, Select |
| FROM: |
Jerry McGinty, Director, Legislative Budget Board
|
| IN RE: |
HB3286 by Klick (Relating to certain prescription drug benefits under the Medicaid managed care program.), As Introduced |
The fiscal implications of the bill cannot be determined due to the uncertainty regarding the number of clients that would shift to non-preferred drugs as a result of step therapy protocol.
The bill would define and apply step therapy protocol for outpatient pharmacy benefit plans, and would require a client to use prescription drugs other than those recommended by their physician, before a Medicaid managed care organization provides coverage for the drug, with certain exceptions. According to the Health and Human Services Commission, the bill could result in a reduction of federal and supplemental rebates due to a shift towards higher net cost non-preferred drugs. However, due to a lack of information regarding the effects on utilization, the fiscal impact cannot be determined at this time.
Local Government Impact
No fiscal implication to units of local government is anticipated.
| Source Agencies: | 529 Health and Human Services Commission |
| LBB Staff: | JMc, NPe, ER, CST |
